Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2020		Dec. 31, 2019
Assets
Cash and cash equivalents	[1]	$ 18,702		$ 17,700
Federal funds sold		85,182		50,121
Equity investments		10,389		10,079
Investment securities		47,495		48,998
Loans		1,260,594		1,160,855
Allowance for losses		(66,977)	[2],[3]	(46,093)
Net loans receivable		1,193,617		1,114,762
Accrued interest receivable		10,643		8,662
Property, equipment, and right-of-use lease asset, net		13,259		14,375
Loan collateral in process of foreclosure	[4]	47,375		52,711
Goodwill		150,803		150,803
Intangible assets, net		51,814		52,536
Income tax receivable		977		1,516
Other assets		21,487		19,404
Total assets		1,651,743		1,541,667
Liabilities
Accounts payable and accrued expenses	[5]	20,647		16,234
Accrued interest payable		4,497		4,398
Deposits	[6]	1,075,322		951,651
Short-term borrowings		60,889		38,223
Deferred tax liabilities		5,562		9,341
Operating lease liabilities		11,655		12,738
Long-term debt	[7]	154,874		174,614
Total liabilities		1,333,446		1,207,199
Commitments and contingencies	[8]
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)
Common stock (50,000,000 shares of $0.01 par value stock authorized- 27,767,619 shares at June 30, 2020 and 27,597,802 shares at December 31, 2019 issued)		278		276
Additional paid in capital		276,495		275,511
Treasury stock (2,951,243 shares at June 30, 2020 and December 31, 2019)		(24,919)		(24,919)
Accumulated other comprehensive income		2,127		999
Retained earnings (deficit)		(6,339)		11,281
Total stockholders’ equity		247,642		263,148
Non-controlling interest in consolidated subsidiaries		70,655		71,320
Total equity		318,297		334,468
Total liabilities and equity		$ 1,651,743		$ 1,541,667
Number of shares outstanding		24,816,376		24,646,559
Book value per share		$ 9.98		$ 10.68

[1] Includes restricted cash of $2,970 as of June 30, 2020 and December 31, 2019.

[2] As of June 30, 2020, there was no allowance for loan loss and net charge-offs related to the strategic partnership loans.

[3] Includes $2,025 of a general reserve for the Company, for current and performing medallion loans under 90 days past due, as an additional buffer against future losses, representing 3% of the total allowance, and 1.94% of the medallion loans under 90 days past due as of June 30, 2020. This figure excludes $17,351 of a general reserve on loans at the Bank, which was netted against loan balances at consolidation on April 2, 2018. Subsequent to April 2, 2018, the Bank recorded a general reserve benefit of $11,555.

[4] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, and that are conducted by the Bank of $9,265 as of June 30, 2020 and $8,163 as of December 31, 2019.

[5] Includes the short-term portion of lease liabilities of $2,117 and $2,085 as of June 30, 2020 and December 31, 2019. Refer to Note 6 for more details.

[6] Includes $2,573 and $2,594 of deferred financing costs as of June 30, 2020 and December 31, 2019.

[7] Includes $2,136 and $2,511 of deferred financing costs as of June 30, 2020 and December 31, 2019.

[8] Refer to Note 10 for details.